Arix Bioscience (ARIX)

Sector:

Financials

112.50p
   
  • Change Today:
    -1.50p
  • 52 Week High: 125.00
  • 52 Week Low: 97.00
  • Currency: UK Pounds
  • Shares Issued: 129.39m
  • Volume: 121,064
  • Market Cap: 145.56m
  • Beta: 0.32

ARIX Overview

Arix Bioscience is a global healthcare and life science company that drives value in private and public companies through operational and strategic direction as well as patient capital

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -26035.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a 0.0
PEG n/a n/a
Pr/Revenue 1299.7 n/a
Pr/Book 0.6  
Latest F'cast
Revenue 3163.4% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ARIX Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 51.17 42.76 32.10p 5.2 n/a n/a n/a 0.0%
31-Dec-19 0.51 (75.57) (53.80)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.48 126.30 96.60p 2.3 n/a n/a n/a 0.0%
31-Dec-21 0.34 (61.08) (0.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.11 (27.58) (23.90)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ARIX Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 n/a n/a 18,815.50p 0.0 n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Latest ARIX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ARIX Market Data

Currency UK Pounds
Share Price 112.50p
Change Today -1.50p
% Change -1.32 %
52 Week High 125.00
52 Week Low 97.00
Volume 121,064
Shares Issued 129.39m
Market Cap 145.56m
Beta 0.32

ARIX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.20% above the market average78.20% above the market average78.20% above the market average78.20% above the market average78.20% above the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average
Price Trend
64.90% above the market average64.90% above the market average64.90% above the market average64.90% above the market average64.90% above the market average
60.66% above the sector average60.66% above the sector average60.66% above the sector average60.66% above the sector average60.66% above the sector average
Income Not Available
Growth
64.81% above the market average64.81% above the market average64.81% above the market average64.81% above the market average64.81% above the market average
57.80% above the sector average57.80% above the sector average57.80% above the sector average57.80% above the sector average57.80% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ARIX Dividends

No dividends found

Trades for 08-Dec-2023

Time Volume / Share Price
11:56 100,000 @ 112.00p
16:35 4,985 @ 112.50p
16:35 2,485 @ 112.50p
16:35 2,500 @ 112.50p
16:23 2,850 @ 114.45p

ARIX Key Personnel

Chair Peregrine D E M Moncreiffe
CEO Robert Lyne

Top of Page